Lymphomatoid granulomatosis associated with azathioprine therapy in Crohn disease
Open Access
- 14 July 2014
- journal article
- case report
- Published by Springer Nature in BMC Gastroenterology
- Vol. 14 (1) , 127
Abstract
Lymphomatoid granulomatosis (LYG) is a rare Epstein-Barr virus-associated lymphoproliferative disorder. It most often occurs in patients with immunodeficiency and the clinical course ranges from indolent behavior to that of an aggressive malignancy. Pulmonary, central nervous system and dermatological manifestations are most common. To our knowledge this is the first reported case of LYG related to azathioprine therapy in Crohn disease.Keywords
This publication has 13 references indexed in Scilit:
- Current histological diagnosis of lymphomatoid granulomatosisLaboratory Investigation, 2012
- Role of Thiopurine and Anti-TNF Therapy in Lymphoma in Inflammatory Bowel DiseaseAmerican Journal of Gastroenterology, 2011
- Lymphomatoid GranulomatosisAmerican Journal of Surgical Pathology, 2010
- Lymphomatoid Granulomatosis: A Unique Complication of Crohn Disease and Its Treatment in PediatricsJournal of Pediatric Gastroenterology and Nutrition, 2010
- Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort studyThe Lancet, 2009
- Noncolorectal Malignancies in Inflammatory Bowel Disease: More than Meets the EyeDigestive Diseases, 2009
- Primary central nervous system lymphomatoid granulomatosis in a patient receiving azathioprine therapy.2009
- Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurineGut, 2005
- Lymphomatoid GranulomatosisNew England Journal of Medicine, 1982
- Lymphomatoid granulomatosisHuman Pathology, 1972